PlainRecalls
FDA Drug Low Class III Terminated

labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Use, SCA Pharmaceuticals, Windsor, CT 06095 --- NDC 70004-0700-28, UPC 70004070028

Reported: March 14, 2018 Initiated: February 22, 2018 #D-0603-2018

Product Description

labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Use, SCA Pharmaceuticals, Windsor, CT 06095 --- NDC 70004-0700-28, UPC 70004070028

Reason for Recall

Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018

Details

Recalling Firm
SCA Pharmaceuticals, LLC.
Units Affected
480 syringes
Distribution
GA, NE & PA
Location
Windsor, CT

Frequently Asked Questions

What product was recalled?
labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Use, SCA Pharmaceuticals, Windsor, CT 06095 --- NDC 70004-0700-28, UPC 70004070028. Recalled by SCA Pharmaceuticals, LLC.. Units affected: 480 syringes.
Why was this product recalled?
Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018
Which agency issued this recall?
This recall was issued by the FDA Drug on March 14, 2018. Severity: Low. Recall number: D-0603-2018.